PCM
GILD icon

Price Capital Management’s Gilead Sciences GILD Stock Holding History

Price Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,456
Closed -$241K – 96
2015
Q1 		$241K Buy
+2,456
New +$249K 0.15% 161

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Price Capital Management's GILD Position: Q2 2015 in Review

Price Capital Management sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 2,456 shares — an estimated $241K sold.

Price Capital Management first reported a position in GILD in Q1 2015 and held it in 1 quarter. The position peaked at $241K in Q1 2015. 1,560 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Price Capital Management reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Price Capital Management sold 2,456 Gilead Sciences shares in Q2 2015, an estimated $241K.
  • Price Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 1 quarter.
  • Price Capital Management's Gilead Sciences position peaked at $241K in Q1 2015.
  • 1,560 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Price Capital Management's 13F filing for Q2 2015.